A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients

NCT01376804 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation, Cytomegalovirus Infections

Interventions

DRUG: valganciclovir [Valcyte]

Sponsor

Hoffmann-La Roche